Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | EVP & Chief Operating Officer | April 01, 2022 | April 05, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date April 01, 2022 · Filed April 05, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $101.09 · Expires 2032-04-01 | Direct | 25,987 |
Reported balance
After 2022-04-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-04-01 · Grant · Acquired 25,987 · Balance 25,987 F1: Option becomes exercisable in four equal installments, commencing 4/1/2023. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $104.82 · Expires 2023-04-01 | Direct | 161,318 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 161,318 F3: Option became exercisable in four equal annual installments, commencing 4/1/2017. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $78.05 · Expires 2024-04-03 | Direct | 200,358 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 200,358 F4: Option became exercisable in four equal annual installments, commencing 4/3/2018. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $62.21 · Expires 2025-04-01 | Direct | 248,131 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 248,131 F5: Option became exercisable in four equal annual installments, commencing 4/1/2019. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $54.19 · Expires 2029-04-01 | Direct | 303,010 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 303,010 F6: Option became exercisable in four equal annual installments, commencing 4/1/2020. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $58.34 · Expires 2030-04-01 | Direct | 239,355 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 239,355 F7: The number of shares subject to the option were calculated using a 30-day average price. F8: Options became exercisable in four equal installments, commencing 4/1/2021. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $74.30 · Expires 2031-04-01 | Direct | 172,772 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 172,772 F9: Option becomes exercisable in four equal installments, commencing 4/1/2022. |
| Common StockSEC Table I · non-derivative | Direct | 426,024.717 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 426,024.717 |
| Common StockSEC Table I · non-derivative | IndirectBy GRAT | 38,192 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 38,192 |
| Common Stock (restricted)SEC Table I · non-derivative | Direct | 12,812 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 12,812 |
| ESOP Common StockSEC Table I · non-derivative | IndirectBy ESOP | 6,155.5059 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 6,155.5059 |
| Stock UnitSEC Table I · non-derivative | Direct | 341,392.3767 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 341,392.3767 |
| Phantom Stock CreditsSEC Table II · derivative / convertible security · Conversion / exercise price $1.00 | Direct | 1,416.3128 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 1,416.3128 F2: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Option becomes exercisable in four equal installments, commencing 4/1/2023.
F2: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F3: Option became exercisable in four equal annual installments, commencing 4/1/2017.
F4: Option became exercisable in four equal annual installments, commencing 4/3/2018.
F5: Option became exercisable in four equal annual installments, commencing 4/1/2019.
F6: Option became exercisable in four equal annual installments, commencing 4/1/2020.
F7: The number of shares subject to the option were calculated using a 30-day average price.
F8: Options became exercisable in four equal installments, commencing 4/1/2021.
F9: Option becomes exercisable in four equal installments, commencing 4/1/2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 07, 2015 Filed Jan 8, 2015 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 86,487 | $41.17 | $3,560,669.79 |
DisclosureSEC source: 0001127602-15-001445 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS/caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,954.7177 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2014 Filed Jan 8, 2015 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 127 | $79.24 | $10,063.48 |
DisclosureSEC source: 0001127602-15-001445 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS/caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,396.9286 Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 73,433 | $74.29 Strike: $74.29 | $5,455,337.57 |
DisclosureSEC source: 0001127602-14-014015 · form4.xml · derivative · entry 6 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,433 Underlying: Common Stock · 73,433 shares Expires 2021-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2015. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 11,778 | $74.29 | $874,987.62 |
DisclosureSEC source: 0001127602-14-014015 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,443 F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2017 and 50% on 4/1/2019. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 2,026 | $74.29 | $150,511.54 |
DisclosureSEC source: 0001127602-14-014015 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,523.9286 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 18, 2014 Filed Feb 20, 2014 21:37 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 18,486 | $70.32 | $1,299,935.52 |
DisclosureSEC source: 0001127602-14-007450 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,194.6057 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| January 02, 2014 Filed Jan 3, 2014 21:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 101,708 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0001127602-14-000798 · form4.xml · derivative · entry 11 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 101,708 shares Expires 2016-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 4/1/2010. Read SEC document |
| January 02, 2014 Filed Jan 3, 2014 21:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 60,484 | $0.00 Strike: $34.42 | $0.00 |
DisclosureSEC source: 0001127602-14-000798 · form4.xml · derivative · entry 10 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,484 shares Expires 2014-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 4/2/2008. Read SEC document |
| January 02, 2014 Filed Jan 3, 2014 21:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 101,708 | $70.61 | $7,181,601.88 |
DisclosureSEC source: 0001127602-14-000798 · form4.xml · nonDerivative · entry 5 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,301.6731 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.19 and $70.97 per share. Read SEC document |
| January 02, 2014 Filed Jan 3, 2014 21:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 101,708 | $28.10 | $2,857,994.80 |
DisclosureSEC source: 0001127602-14-000798 · form4.xml · nonDerivative · entry 4 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,009.6731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2014 Filed Jan 3, 2014 21:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 60,484 | $70.61 | $4,270,775.24 |
DisclosureSEC source: 0001127602-14-000798 · form4.xml · nonDerivative · entry 3 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,301.6731 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.19 and $70.97 per share. Read SEC document |
| January 02, 2014 Filed Jan 3, 2014 21:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 60,484 | $34.42 | $2,081,859.28 |
DisclosureSEC source: 0001127602-14-000798 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,785.6731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 05, 2013 Filed Jan 3, 2014 21:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 850 | $58.46 | $49,691.00 |
DisclosureSEC source: 0001127602-14-000798 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,228.6731 Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 68,844 | $54.53 Strike: $54.53 | $3,754,063.32 |
DisclosureSEC source: 0001127602-13-013257 · form4.xml · derivative · entry 6 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,844 Underlying: Common Stock · 68,844 shares Expires 2020-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 5,822 | $54.53 | $317,473.66 |
DisclosureSEC source: 0001127602-13-013257 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,078.6731 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 16,047 | $54.53 | $875,042.91 |
DisclosureSEC source: 0001127602-13-013257 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,333 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2016 and 50% on 4/1/2018. Read SEC document |
| February 19, 2013 Filed Feb 21, 2013 21:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 9,536 | $52.66 | $502,165.76 |
DisclosureSEC source: 0001127602-13-007332 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,384.6748 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| December 19, 2012 Filed Feb 11, 2013 21:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 2,150 | $49.05 | $105,446.75 |
DisclosureSEC source: 0001127602-13-005356 · form5.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,755.6731 Read SEC document |
| September 04, 2012 Filed Sep 5, 2012 19:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 64,546 | $0.00 Strike: $30.04 | $0.00 |
DisclosureSEC source: 0001127602-12-025762 · form4.xml · derivative · entry 7 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 64,546 shares Expires 2013-04-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 4/3/2007. Read SEC document |
| September 04, 2012 Filed Sep 5, 2012 19:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 32,273 | $45.55 | $1,470,035.15 |
DisclosureSEC source: 0001127602-12-025762 · form4.xml · nonDerivative · entry 3 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,819.2866 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $45.45 and $45.63 per share. Read SEC document |
| September 04, 2012 Filed Sep 5, 2012 19:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 32,273 | $45.54 | $1,469,712.42 |
DisclosureSEC source: 0001127602-12-025762 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,092.2866 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $45.46 and $45.66 per share. Read SEC document |
| September 04, 2012 Filed Sep 5, 2012 19:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 64,546 | $30.04 | $1,938,639.11 |
DisclosureSEC source: 0001127602-12-025762 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,365.2866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 04, 2012 Filed Sep 6, 2012 20:08 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 108,870 | $45.93 Strike: $45.93 | $5,000,399.10 |
DisclosureSEC source: 0001127602-12-025885 · form4.xml · derivative · entry 6 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,870 Underlying: Common Stock · 108,870 shares Expires 2022-09-04 F2 · shares: Options become exercisable in three equal annual installments, commencing 9/4/2015. Read SEC document |
| September 04, 2012 Filed Sep 6, 2012 20:08 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (pep) | 10,887 | $45.93 | $500,039.91 |
DisclosureSEC source: 0001127602-12-025885 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,887 F1 · shares: Consists of Matching Restricted Stock Units awarded pursuant to Issuer's Partnership Equity Program under the 2010 Incentive Compensation Plan. Restrictions lapse on September 4, 2017. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:09 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 77,639 | $45.07 Strike: $45.07 | $3,499,189.73 |
DisclosureSEC source: 0001127602-12-013297 · form4.xml · derivative · entry 5 Roberts Jonathan C · CIK 0001410515 · EVP & COO, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,639 Underlying: Common Stock · 77,639 shares Expires 2019-04-02 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:09 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,794 | $45.07 | $80,855.58 |
DisclosureSEC source: 0001127602-12-013297 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & COO, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,819.2866 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:09 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 19,415 | $45.07 | $875,034.05 |
DisclosureSEC source: 0001127602-12-013297 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & COO, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,228 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/2/2015 and 50% on 4/2/2017. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 22:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 7,347 | $43.08 | $316,508.76 |
DisclosureSEC source: 0001127602-12-004969 · form4.xml · nonDerivative · entry 3 Roberts Jonathan C · CIK 0001410515 · EVP & COO, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,302.9506 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan. Read SEC document |
| December 20, 2011 Filed Feb 9, 2012 22:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 2,348 | $39.80 | $93,450.40 |
DisclosureSEC source: 0001127602-12-004969 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & COO, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,955.9506 Read SEC document |
| December 13, 2011 Filed Feb 9, 2012 22:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 308 | $37.69 | $11,608.52 |
DisclosureSEC source: 0001127602-12-004969 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & COO, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,303.9506 Read SEC document |
| September 01, 2011 Filed Sep 6, 2011 20:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 48,000 | $0.00 Strike: $22.45 | $0.00 |
DisclosureSEC source: 0001127602-11-024799 · form4.xml · derivative · entry 6 Roberts Jonathan C · CIK 0001410515 · EVP & COO, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 48,000 shares Expires 2012-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 1/5/2006. Read SEC document |
| September 01, 2011 Filed Sep 6, 2011 20:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 48,000 | $36.01 | $1,728,480.00 |
DisclosureSEC source: 0001127602-11-024799 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & COO, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,611.9506 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $35.81 and $36.25 per share. Read SEC document |
| September 01, 2011 Filed Sep 6, 2011 20:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 48,000 | $22.45 | $1,077,360.00 |
DisclosureSEC source: 0001127602-11-024799 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & COO, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,611.9506 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2011 Filed Apr 5, 2011 20:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 85,743 | $34.96 Strike: $34.96 | $2,997,575.28 |
DisclosureSEC source: 0001127602-11-012422 · form4.xml · derivative · entry 5 Roberts Jonathan C · CIK 0001410515 · EVP & COO, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,743 Underlying: Common Stock · 85,743 shares Expires 2018-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2012. Read SEC document |
| April 01, 2011 Filed Apr 5, 2011 20:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 22,884 | $34.96 | $800,024.64 |
DisclosureSEC source: 0001127602-11-012422 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & COO, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,857 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse in two equal installments, 50% on 4/1/2014 and 50% on 4/1/2016. Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 20:45 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 24,000 | $0.00 Strike: $30.26 | $0.00 |
DisclosureSEC source: 0001127602-11-005014 · form4.xml · derivative · entry 7 Roberts Jonathan C · CIK 0001410515 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,000 shares Expires 2011-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 3/7/2003. Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 20:45 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 24,000 | $33.40 | $801,600.00 |
DisclosureSEC source: 0001127602-11-005014 · form4.xml · nonDerivative · entry 3 Roberts Jonathan C · CIK 0001410515 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,549.0839 Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 20:45 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 24,000 | $30.26 | $726,300.00 |
DisclosureSEC source: 0001127602-11-005014 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,549.0839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2010 Filed Feb 11, 2011 20:45 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 3,300 | $35.14 | $115,962.00 |
DisclosureSEC source: 0001127602-11-005014 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,549.0839 Read SEC document |
| April 01, 2010 Filed Apr 5, 2010 22:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 61,196 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-10-010572 · form4.xml · derivative · entry 5 Roberts Jonathan C · CIK 0001410515 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,196 Underlying: Common Stock · 61,196 shares Expires 2017-04-01 F2 · shares: Option becomes exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| April 01, 2010 Filed Apr 5, 2010 22:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 5,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-010572 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,244 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 4/1/2013 and 50% on 4/1/2015. Read SEC document |
| February 17, 2010 Filed Feb 19, 2010 21:10 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 6,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-005629 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,404 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| June 17, 2009 Filed Jun 19, 2009 19:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 48,000 | $0.00 Strike: $17.67 | $0.00 |
DisclosureSEC source: 0001127602-09-014321 · form4.xml · derivative · entry 11 Roberts Jonathan C · CIK 0001410515 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 48,000 shares Expires 2011-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 1/8/2005. Read SEC document |
| June 17, 2009 Filed Jun 19, 2009 19:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 22,000 | $0.00 Strike: $19.28 | $0.00 |
DisclosureSEC source: 0001127602-09-014321 · form4.xml · derivative · entry 10 Roberts Jonathan C · CIK 0001410515 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,000 shares Expires 2012-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 1/3/2002. Read SEC document |
| June 17, 2009 Filed Jun 19, 2009 19:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 34,000 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0001127602-09-014321 · form4.xml · derivative · entry 9 Roberts Jonathan C · CIK 0001410515 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,000 shares Expires 2012-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 1/2/2004. Read SEC document |
| June 17, 2009 Filed Jun 19, 2009 19:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 104,000 | $31.06 | $3,230,728.80 |
DisclosureSEC source: 0001127602-09-014321 · form4.xml · nonDerivative · entry 5 Roberts Jonathan C · CIK 0001410515 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,849.0839 Read SEC document |
| June 17, 2009 Filed Jun 19, 2009 19:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 48,000 | $17.67 | $848,040.00 |
DisclosureSEC source: 0001127602-09-014321 · form4.xml · nonDerivative · entry 4 Roberts Jonathan C · CIK 0001410515 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,849.0839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2009 Filed Jun 19, 2009 19:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 22,000 | $19.28 | $424,188.60 |
DisclosureSEC source: 0001127602-09-014321 · form4.xml · nonDerivative · entry 3 Roberts Jonathan C · CIK 0001410515 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,849.0839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2009 Filed Jun 19, 2009 19:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 34,000 | $14.96 | $508,725.00 |
DisclosureSEC source: 0001127602-09-014321 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,849.0839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2009 Filed Jun 19, 2009 19:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 3,375 | $30.52 | $103,005.00 |
DisclosureSEC source: 0001127602-09-014321 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,849.0839 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.